“Adoption of safety-engineered syringes is absolutely critical to protecting people worldwide from being infected with HIV, hepatitis and other diseases,” said Gottfried Hirnschall, MD, director of WHO’s HIV/AIDS department. “This should be an urgent priority for all countries.”
The WHO-recommended syringes for injections into muscle or skin have features that prevent re-use. Also, other “smart” syringes help prevent needle stick injuries by sliding a sheath or hood over the needle after the injection is completed.
The WHO urges countries to exclusively use new “smart” syringes in all but a few special circumstances by 2020. One roadblock to reaching this goal is expense: “smart” syringes cost nearly twice as much as syringes without safety features, according to the WHO. Therefore, the agency urges donors to help with this transition and hopes prices will fall as demand increases.
More articles on safe injections:
Global needlestick safety injection device market: 5 things to know
20 patient safety tools
Multi-dose vials: What’s the point?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
